IL310556A - Purification processes using cation exchange chromatography for drug-antibody conjugates - Google Patents
Purification processes using cation exchange chromatography for drug-antibody conjugatesInfo
- Publication number
- IL310556A IL310556A IL310556A IL31055624A IL310556A IL 310556 A IL310556 A IL 310556A IL 310556 A IL310556 A IL 310556A IL 31055624 A IL31055624 A IL 31055624A IL 310556 A IL310556 A IL 310556A
- Authority
- IL
- Israel
- Prior art keywords
- flow
- cation exchange
- exchange chromatography
- drug conjugates
- antibody drug
- Prior art date
Links
- 239000000611 antibody drug conjugate Substances 0.000 title 1
- 229940049595 antibody-drug conjugate Drugs 0.000 title 1
- 238000005277 cation exchange chromatography Methods 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236170P | 2021-08-23 | 2021-08-23 | |
| PCT/US2022/075252 WO2023028446A1 (en) | 2021-08-23 | 2022-08-22 | Flow through cation exchange chromatography purification processes for antibody drug conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL310556A true IL310556A (en) | 2024-03-01 |
Family
ID=83271094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL310556A IL310556A (en) | 2021-08-23 | 2022-08-22 | Purification processes using cation exchange chromatography for drug-antibody conjugates |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240277859A1 (enExample) |
| EP (1) | EP4392433A1 (enExample) |
| JP (1) | JP2024532238A (enExample) |
| KR (1) | KR20240046733A (enExample) |
| CN (1) | CN117881686A (enExample) |
| AR (1) | AR126847A1 (enExample) |
| AU (1) | AU2022332274A1 (enExample) |
| CA (1) | CA3229079A1 (enExample) |
| IL (1) | IL310556A (enExample) |
| MX (1) | MX2024002133A (enExample) |
| TW (1) | TW202323268A (enExample) |
| WO (1) | WO2023028446A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118290513B (zh) * | 2024-06-05 | 2025-03-14 | 东曜药业有限公司 | 一种去除抗体偶联药物中游离小分子的阴离子柱层析方法及抗体偶联药物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1869065T3 (da) | 2005-03-11 | 2020-06-08 | Wyeth Llc | Fremgangsmåde til kromatografi med svag opdeling |
| WO2012059308A1 (en) * | 2010-11-01 | 2012-05-10 | Dsm Ip Assets B.V. | Single unit ion exchange chromatography antibody purification |
| SG10201701224UA (en) | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
| CN104208719B (zh) * | 2014-09-24 | 2017-05-03 | 北京天广实生物技术股份有限公司 | 一种抗体偶联药物的阳离子交换层析纯化方法 |
| US20180311375A1 (en) * | 2017-04-27 | 2018-11-01 | Cadila Healthcare Limited | Process of preparing antibody-drug conjugate |
-
2022
- 2022-08-22 JP JP2024510666A patent/JP2024532238A/ja active Pending
- 2022-08-22 US US18/682,046 patent/US20240277859A1/en active Pending
- 2022-08-22 AR ARP220102261A patent/AR126847A1/es unknown
- 2022-08-22 MX MX2024002133A patent/MX2024002133A/es unknown
- 2022-08-22 CN CN202280056541.9A patent/CN117881686A/zh active Pending
- 2022-08-22 CA CA3229079A patent/CA3229079A1/en active Pending
- 2022-08-22 EP EP22768589.8A patent/EP4392433A1/en active Pending
- 2022-08-22 IL IL310556A patent/IL310556A/en unknown
- 2022-08-22 AU AU2022332274A patent/AU2022332274A1/en active Pending
- 2022-08-22 KR KR1020247006568A patent/KR20240046733A/ko active Pending
- 2022-08-22 WO PCT/US2022/075252 patent/WO2023028446A1/en not_active Ceased
- 2022-08-22 TW TW111131425A patent/TW202323268A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022332274A1 (en) | 2024-02-15 |
| MX2024002133A (es) | 2024-03-06 |
| EP4392433A1 (en) | 2024-07-03 |
| AR126847A1 (es) | 2023-11-22 |
| US20240277859A1 (en) | 2024-08-22 |
| CA3229079A1 (en) | 2023-03-02 |
| KR20240046733A (ko) | 2024-04-09 |
| TW202323268A (zh) | 2023-06-16 |
| CN117881686A (zh) | 2024-04-12 |
| WO2023028446A1 (en) | 2023-03-02 |
| JP2024532238A (ja) | 2024-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL239495B (en) | Antibody purification using cation exchange chromatography | |
| CY1125281T1 (el) | Διαδικασια συνεχους ροης πολλαπλων σταδιων για τον καθαρμο αντισωματων | |
| TR201818614T4 (tr) | Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem | |
| MX373458B (es) | Metodo para purificar conjugados de anticuerpo-farmaco enlazados a cisteina. | |
| HUE036548T2 (hu) | IL-31-re specifikus humanizált antitest molekulák | |
| BRPI0718130A2 (pt) | Anticorpos anti-cd38 para tratamento de câncer | |
| LT3421498T (lt) | Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui | |
| EP2193295A4 (en) | CLOSURE ASSEMBLY FOR A CHROMATOGRAPHIC PILLAR | |
| IL286982A (en) | A method for purifying an fc region-modified antibody | |
| EP1909832A4 (en) | ANTIBODY IMMUNOCELL LIGAND FUSION PROTEIN FOR CANCER THERAPY | |
| LT3663401T (lt) | Biologinių molekulių, tokių kaip plazmidinė dnr, gryninimo būdas, panaudojant anijonų mainų chromatografiją | |
| FR2911793B1 (fr) | Procede de separation par chromatographie | |
| PL2748179T3 (pl) | Oczyszczanie białka metodą anionowej chromatografii jonowymiennej | |
| EP3684409A4 (en) | SEPARATION OF TRIPLE LIGHT CHAIN ANTIBODIES USING CATION EXCHANGE CHROMATOGRAPHY | |
| EP2987801A4 (en) | PROCESS FOR PURIFYING ANTIBODY PROTEIN | |
| EP1938097A4 (en) | SYSTEM WITH CHANGING FLOW SPEED FOR COLUMN CHROMATOGRAPHY | |
| FR2908125B1 (fr) | Procede de purification de silicium metallurgique par solidification dirigee | |
| EP3519351A4 (en) | CLEANING PROCEDURE FOR PROTEIN-NANOPARTICLE CONJUGATE | |
| EP3917559C0 (en) | THERAPEUTIC PROTEIN FLOW KIT FOR A CONTINUOUS PURIFICATION SYSTEM | |
| FR2900082B1 (fr) | Procede de soudage par friction malaxage | |
| FR2907687B1 (fr) | Procede de purification de sialyllactose par chromatographie | |
| MX2024002133A (es) | Procesos de purificacion por cromatografia de intercambio cationico de flujo continuo para conjugados anticuerpo-farmaco. | |
| EP4262863A4 (en) | PURIFICATION OF ENTEROVIRUS FOR CATION EXCHANGE CHROMATOGRAPHY | |
| FR3024142B1 (fr) | Procede de purification de glycol utilise comme agent anti-hydrate | |
| BR112014004361A2 (pt) | radiossíntese simplificada de derivados o-[18f]fluormetil tirosina |